Itau Unibanco Holding S.A. Tg Therapeutics, Inc. Transaction History

Itau Unibanco Holding S.A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$13.32 - $19.19 $1,625 - $2,341	122 New	122 $2,000
Q4 2023 Feb 14, 2024	SELL	$6.68 - $18.81 $227 - $639	-34 Reduced 15.18%	190 $3,000
Q3 2023 Nov 14, 2023	SELL	$8.36 - $26.5 $33 - $106	-4 Reduced 1.75%	224 $1,000
Q2 2023 Aug 14, 2023	BUY	$15.48 - $35.0 $3,529 - $7,980	228 New	228 $5,000
Q4 2021 Feb 14, 2022	SELL	$15.2 - $35.51 $6,186 - $14,452	-407 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$21.78 - $40.45 $217 - $404	10 Added 2.52%	407 $14,000
Q2 2021 Aug 17, 2021	BUY	$32.5 - $48.96 $12,902 - $19,437	397 New	397 $15,000

338

88.3M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.29B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.